Volume 30, Number 12—December 2024
CME ACTIVITY - Research
Ophthalmic Sequelae of Ebola Virus Disease in Survivors, Sierra Leone
Table 3
Ophthalmic findings | No. (%) patients, n = 521 | No. (%) eyes, n = 1,042 |
---|---|---|
Any ophthalmic finding | 200 (38.4) | 358 (34.4) |
Cataract | 62 (11.9) | 117 (11.2) |
Uveitic cataract | 10 (16.1) | 17 (14.5) |
Uveitis | 69 (13.2) | 86 (8.3) |
Anterior uveitis | 34 (49.3) | 44 (51.2) |
Intermediate uveitis | 1 (1.4) | 1 (1.2) |
Anterior/intermediate uveitis | 4 (5.8) | 5 (5.8) |
Posterior uveitis | 13 (18.8) | 16 (18.6) |
Panuveitis | 15 (21.7) | 17 (19.8) |
Unspecified | 2 (2.9) | 3 (3.5) |
Dry eyes | 41 (7.9) | 81 (7.8) |
Chorioretinal scar | 56 (10.7) | 68 (6.5) |
Pterygium | 20 (3.8) | 43 (4.1) |
Drusen | 20 (3.8) | 36 (3.5) |
Refractive error | 18 (3.5) | 35 (3.4) |
Corneal scar | 22 (4.2) | 28 (2.7) |
Vitreous hemorrhage | 9 (1.7) | 16 (1.6) |
Optic neuropathy | 6 (1.2) | 7 (0.7) |
1These authors were co–principal investigators.
Page created: November 04, 2024
Page updated: November 22, 2024
Page reviewed: November 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.